Clinical trial
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Effect of Collagen Peptide on Perceived Gastrointestinal Discomfort in Healthy Adult Participants With Presence of Gastrointestinal Symptoms
NCT06937801 is registered in ClinicalTrials.gov with Rousselot BVBA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Effect of Collagen Peptide on Perceived Gastrointestinal Discomfort in Healthy Adult Participants With Presence of Gastrointestinal Symptoms
- Lead sponsor
- Rousselot BVBA
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 8, 2025
- Completion date
- November 21, 2025
- Enrollment
- 116 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal disorders